New Approach to the Management of the Suicidal Patient
|
By HospiMedica International staff writers Posted on 24 Dec 2014 |
A new study suggests that an adjunctive acceptance and commitment therapy (ACT) group program could be effective in treating suicidal behaviors.
Researchers at Academic Hospital of Montpellier (France) and Lapeyronie Hospital (Montpellier, France) conducted a study involving 35 outpatients suffering from a current suicidal behavior disorder (SBD), which is defined (according to DSM-5) as a history of suicidal attempt in the past year. The patients were included in an ACT program, and were assessed at inclusion, after one week, and three months after program completion. Exclusion criteria were current mania or depressive episodes, or schizophrenia.
The results showed that between inclusion and the one week follow-up, there was a significant reduction in the intensity of suicidal ideations during the last 15 days. There was also a significant reduction in depression symptoms, anxiety state, hopelessness, and psychological pain, and a significant improvement in global functioning and quality of life. All the differences remained significant at three month follow up, and dosages of benzodiazepines were reduced for 65% of the patients. Notably, there was no suicide reattempt during the follow-up period. The study was published on December 9, 2014, in the Journal of Psychotherapy and Psychosomatics.
“ACT, a ‘third-wave' behavioral therapy, specifically focuses on experiential avoidance, that is the tendency to avoid unwanted thoughts or emotions, at the core of psychiatric disorders,” concluded lead author Deborah Ducasse, MD, of the department of psychiatric emergency and acute crisis at Lapeyronie Hospital. “This may be a key aspect in suicidal subjects who often report intrusive mental images of suicide that they try to suppress, increasing in their intensity and frequency, independently from depressive symptoms.”
ACT is a is an empirically based psychological intervention that uses acceptance and mindfulness strategies mixed in different ways with commitment and behavior-change strategies to increase psychological flexibility. Rather than trying to teach people to better control their thoughts, feelings, sensations, and memories as in traditional cognitive behavioral therapy (CBT), ACT teaches them to observe, accept, and embrace their private events, especially previously unwanted ones. The method was developed in the late 1980s.
Related Links:
Academic Hospital of Montpellier
Lapeyronie Hospital
Researchers at Academic Hospital of Montpellier (France) and Lapeyronie Hospital (Montpellier, France) conducted a study involving 35 outpatients suffering from a current suicidal behavior disorder (SBD), which is defined (according to DSM-5) as a history of suicidal attempt in the past year. The patients were included in an ACT program, and were assessed at inclusion, after one week, and three months after program completion. Exclusion criteria were current mania or depressive episodes, or schizophrenia.
The results showed that between inclusion and the one week follow-up, there was a significant reduction in the intensity of suicidal ideations during the last 15 days. There was also a significant reduction in depression symptoms, anxiety state, hopelessness, and psychological pain, and a significant improvement in global functioning and quality of life. All the differences remained significant at three month follow up, and dosages of benzodiazepines were reduced for 65% of the patients. Notably, there was no suicide reattempt during the follow-up period. The study was published on December 9, 2014, in the Journal of Psychotherapy and Psychosomatics.
“ACT, a ‘third-wave' behavioral therapy, specifically focuses on experiential avoidance, that is the tendency to avoid unwanted thoughts or emotions, at the core of psychiatric disorders,” concluded lead author Deborah Ducasse, MD, of the department of psychiatric emergency and acute crisis at Lapeyronie Hospital. “This may be a key aspect in suicidal subjects who often report intrusive mental images of suicide that they try to suppress, increasing in their intensity and frequency, independently from depressive symptoms.”
ACT is a is an empirically based psychological intervention that uses acceptance and mindfulness strategies mixed in different ways with commitment and behavior-change strategies to increase psychological flexibility. Rather than trying to teach people to better control their thoughts, feelings, sensations, and memories as in traditional cognitive behavioral therapy (CBT), ACT teaches them to observe, accept, and embrace their private events, especially previously unwanted ones. The method was developed in the late 1980s.
Related Links:
Academic Hospital of Montpellier
Lapeyronie Hospital
Latest Critical Care News
- Implantable Wireless Light Device Advance Bladder Cancer Treatment
- Smart Wristband Technology Detects Cardiac Arrest and Alerts Responders
- FDA-Cleared Home Sleep Test Enables Multi-Night Diagnosis of Sleep Apnea
- AI-Enabled Wearable Patches Reveal Undetected Hormone Disruption in Infertility
- AI Method Turns Toe Scan into Rapid PAD Screening Tool
- Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up
- AI Model Predicts 10-Year Stroke Risk from Standard ECG
- Portable Ultrasound Tool Quantifies Liver Fat with MRI-Like Accuracy
- AI Tool Predicts Risk of Out-of-Hospital Cardiac Arrest
- Implantable Cytokine Device Enables Localized Immunotherapy for Ovarian Cancer
- Wearable Defibrillator Supports Quicker Beta-Blocker Optimization in Women
- High-Frequency Ultrasound Disables Viruses While Sparing Human Cells
- New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke
- AI-Enhanced ECG Screens for Heart Failure Risk in Resource-Limited Settings
- Single-Lead AI ECG Tool Detects Moderate-to-Severe Hyperkalemia Outside Clinic
- Reduced-Intensity Transplant Regimen Expands Donor Access in Sickle Cell Disease
Channels
Artificial Intelligence
view channel
Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening
Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. Providers and trial... Read more
FDA-Cleared AI System Detects Sepsis Earlier and Reduces Mortality
Sepsis remains one of the deadliest complications for hospitalized patients, in part because its early signs overlap with other conditions. Each hour of delayed recognition measurably decreases survival,... Read moreSurgical Techniques
view channel
BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures
BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study
Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
FDA-Cleared Nerve Stimulator Advances Intraoperative Peripheral Nerve Assessment
The Evala Nerve Stimulator from Epineuron (Mississauga, ON, Canada) is a handheld, intraoperative electrical stimulation system designed to provide surgeons with a rapid and accurate method for nerve identification... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
EHR-Integrated Screening Workflow Detects Cognitive Impairment at Admission
Cognitive impairment involves difficulties with thinking, learning, memory, and decision-making, and is more common in older adults. In U.S. hospitals, more than 40% of admitted older adults have dementia,... Read more
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings
Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read morePoint of Care
view channel
Point-of-Care Viscoelastic Testing System Supports Obstetric Bleeding Management
HemoSonics (Durham, NC, USA) announced on May 5, 2026 that the company's Quantra Hemostasis System for Obstetric Procedures won Silver in the 2026 Edison Awards in the Women’s Health and Reproductive Innovations... Read moreBusiness
view channel
Olympus Partnership Aims to Expand Access to Robot-Assisted Endoscopic Therapy
Olympus has signed an exclusive global distribution agreement with EndoRobotics Co., Ltd., under which robot-assisted technologies developed by EndoRobotics will be distributed worldwide as part of the... Read more







